Next Article in Journal
Diagnostic Accuracy of Magnetic Resonance Imaging in the Detection of Type and Location of Meniscus Tears: Comparison with Arthroscopic Findings
Next Article in Special Issue
Serum Anti-Heart and Anti-Intercalated Disk Autoantibodies: Novel Autoimmune Markers in Cardiac Sarcoidosis
Previous Article in Journal
COVID-19 in Autoinflammatory Diseases with Immunosuppressive Treatment
Previous Article in Special Issue
Outcomes of Mechanical Circulatory Support for Giant Cell Myocarditis: A Systematic Review
Review

Epidemiological Impact of Myocarditis

1
Campus Benjamin Franklin, Charite Universitätsmedizin Berlin, 12203 Berlin, Germany
2
Department of Medicine, Cantonal Hospital of Baden, 15005 Baden, Switzerland
3
Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC V5K0A1, Canada
*
Author to whom correspondence should be addressed.
Academic Editor: Andrea Frustaci
J. Clin. Med. 2021, 10(4), 603; https://doi.org/10.3390/jcm10040603
Received: 13 January 2021 / Revised: 24 January 2021 / Accepted: 1 February 2021 / Published: 5 February 2021
(This article belongs to the Special Issue Myocarditis in Clinical Practice)
Myocarditis is an inflammatory disease of the heart muscle with a wide range of potential etiological factors and consequently varying clinical patterns across the world. In this review, we address the epidemiology of myocarditis. Myocarditis was considered a rare disease until intensified research efforts in recent decades revealed its true epidemiological importance. While it remains a challenge to determine the true prevalence of myocarditis, studies are underway to obtain better approximations of the proportions of this disease. Nowadays, the prevalence of myocarditis has been reported from 10.2 to 105.6 per 100,000 worldwide, and its annual occurrence is estimated at about 1.8 million cases. This wide range of reported cases reflects the uncertainty surrounding the true prevalence and a potential underdiagnosis of this disease. Since myocarditis continues to be a significant public health issue, particularly in young adults in whom myocarditis is among the most common causes of sudden cardiac death, improved diagnostic and therapeutic procedures are necessary. This manuscript aims to summarize the current knowledge on the epidemiology of myocarditis, new diagnostic approaches and the current epidemiological impact of the COVID-19 pandemic. View Full-Text
Keywords: myocarditis; epidemiology; incidence and prevalence; myocarditis associated with COVID-19; etiology; diagnosis; regional differences myocarditis; epidemiology; incidence and prevalence; myocarditis associated with COVID-19; etiology; diagnosis; regional differences
Show Figures

Figure 1

MDPI and ACS Style

Golpour, A.; Patriki, D.; Hanson, P.J.; McManus, B.; Heidecker, B. Epidemiological Impact of Myocarditis. J. Clin. Med. 2021, 10, 603. https://doi.org/10.3390/jcm10040603

AMA Style

Golpour A, Patriki D, Hanson PJ, McManus B, Heidecker B. Epidemiological Impact of Myocarditis. Journal of Clinical Medicine. 2021; 10(4):603. https://doi.org/10.3390/jcm10040603

Chicago/Turabian Style

Golpour, Ainoosh, Dimitri Patriki, Paul J. Hanson, Bruce McManus, and Bettina Heidecker. 2021. "Epidemiological Impact of Myocarditis" Journal of Clinical Medicine 10, no. 4: 603. https://doi.org/10.3390/jcm10040603

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop